This powerful tool offers access to a rich set of Discovery based performance metrics. The only tool of its kind based on validated and complete portfolio information from leading biopharma companies of the world. The application provides R&D with insight into research performance at the Target, Discovery Project and Effort level. Discovery Metrix covers 4 key performance categories (Pipeline, Success Rates, Cycle Times, Entry) and offers users the flexibility to create custom views based on a variety of characteristics that include Target Class, TA, disease, origin, modality and more. The peerless data set and resulting analytics makes this tool the trusted source for R&D executives globally.
Most Recent Data Update: May 04, 2021
Discovery Metrix is one tool in the R&D Advantage Suite, benchmarks to drive Research performance and improve productivity